Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of hypovolaemia in the acidosis of severe malaria
ISRCTN35536139Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes, Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of albumin (human), gelatin, dextran-70 and hetastarch in Malaria (4 arms), sponsored by Imperial College London. Primary endpoints: Resolution of clinical features of shock and Case fatality. Started Nov 2004; status: completed.
02
Drugs
albumin (human)gelatindextran-70hetastarch
03
Conditions
Malaria
Beyond the preview
Go deeper on ISRCTN35536139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN35536139.